RANI
Rani Therapeutics Holdings, Inc.$0.77-0.03 (-4.03%)Prev Close$0.80·MCap$58.1M·P/E—·Vol808.6K·Yield—
▲
Buys (12M)
1
$1.26M
▼
Sells (12M)
0
$0.00
◆
Net Activity
Net Buyer
$1.26M
●
Active Insiders
1
last 12 mo
Over the past 12 months, insider activity at Rani Therapeutics Holdings, Inc. (RANI) has been exclusively buying, with 1 insider purchase totaling $1.26M and 0 insider sales totaling $0.00. The most recent insider transaction was by IMRAN MIR A (Director), who purchased $1.26M worth of shares on Oct 23, 2025. Rani Therapeutics Holdings, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $58.1M.
RANI Insider Trading Activity
Showing 1–50 of 56
1 / 2
RANI Insider Buying Activity
The following table shows recent insider purchases of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
RANI Insider Selling Activity
The following table shows recent insider sales of Rani Therapeutics Holdings, Inc. (RANI) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Oct 17, 2024 | South Cone Investments Limited Partnership | 10% Owner | Sell | 3,829,360 | $2.65 | $10.14M5.9% OS | 8,825,932-30% |
| Dec 8, 2023 | Quiroga Cortes Isidoro Alfonso | 10% Owner | Sell | 5,265,165 | $2.01 | $10.58M8.1% OS | 8,400-100% |
RANI Insiders
South Cone Investments Limited Partnership
10% Owner
Bought $12.78MSold $10.14M
40 tradesLast: Oct 17, 2024
Similar Stocks to RANI
VRTX
Vertex Pharmaceuticals Incorporated
$445.21+0.04%
$113.41B
REGN
Regeneron Pharmaceuticals, Inc.
$614.20+0.45%
$65.47B
ALNY
Alnylam Pharmaceuticals, Inc.
$283.35-2.09%
$40.46B
RVMD
Revolution Medicines, Inc.
$153.65+2.96%
$31.73B
UTHR
United Therapeutics Corporation
$542.43-0.54%
$23.12B
INSM
Insmed Incorporated
$98.28+1.64%
$20.41B
INCY
Incyte Corporation
$108.85+0.95%
$20.11B
MRNA
Moderna, Inc.
$50.18+1.06%
$18.89B